Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
+11.1%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$79B
AUM Growth
+$5.52B
(+7.5%)
Cap. Flow
-$7.71B
Cap. Flow
% of AUM
-9.75%
Top 10 Holdings %
Top 10 Hldgs %
24.46%
Holding
2,612
New
284
Increased
737
Reduced
832
Closed
260
Top Buys
| 1 |
Chubb
CB
|
+$574M |
| 2 |
American Electric Power
AEP
|
+$284M |
| 3 |
Ulta Beauty
ULTA
|
+$187M |
| 4 |
CVS Health
CVS
|
+$177M |
| 5 |
McDonald's
MCD
|
+$151M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$422M |
| 2 |
Johnson & Johnson
JNJ
|
+$213M |
| 3 |
Aon
AON
|
+$192M |
| 4 |
Norfolk Southern
NSC
|
+$183M |
| 5 |
CyberArk
CYBR
|
+$168M |
Sector Composition
| 1 | Technology | 20.99% |
| 2 | Financials | 14.11% |
| 3 | Healthcare | 13.38% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Capri Holdings
CPRI
$2.54B
| $24K | ﹤0.01% |
485
-107
| -18% | -$5.3K |
|
1852
Comstock Resources
CRK
$4.65B
| $24K | ﹤0.01% |
2,790
-98,793
| -97% | -$850K |
|
1853
Green Dot
GDOT
$757M
| $24K | ﹤0.01% |
+2,428
| New | +$24K |
|
|
PSTX
1854
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $24K | ﹤0.01% |
7,541
-24,523
| -76% | -$78K |
|
|
VTRU
1855
DELISTED
Vitru Limited Common Shares
VTRU
| $24K | ﹤0.01% |
1,531
+15
| +1% | +$235 |
|
1856
Cross Country Healthcare
CCRN
$455M
| $23K | ﹤0.01% |
1,049
+26
| +3% | +$570 |
|
1857
Lyell Immunopharma
LYEL
$251M
| $23K | ﹤0.01% |
620
+325
| +110% | +$12.1K |
|
1858
TScan Therapeutics
TCRX
$104M
| $22K | ﹤0.01% |
+3,983
| New | +$22K |
|
1859
Ambac
AMBC
$415M
| $22K | ﹤0.01% |
1,371
-320
| -19% | -$5.14K |
|
1860
JPMorgan BetaBuilders US Equity ETF
BBUS
$5.42B
| $22K | ﹤0.01% |
261
| – | – |
|
1861
Broadridge
BR
$29.3B
| $22K | ﹤0.01% |
107
+102
| +2,040% | +$21K |
|
1862
Phinia Inc
PHIN
$2.26B
| $22K | ﹤0.01% |
754
-7
| -0.9% | -$204 |
|
1863
Plumas Bancorp
PLBC
$313M
| $22K | ﹤0.01% |
+555
| New | +$22K |
|
1864
STAAR Surgical
STAA
$1.37B
| $22K | ﹤0.01% |
721
-168
| -19% | -$5.13K |
|
1865
CryoPort
CYRX
$480M
| $21K | ﹤0.01% |
1,364
-139
| -9% | -$2.14K |
|
1866
Dine Brands
DIN
$361M
| $21K | ﹤0.01% |
432
-632
| -59% | -$30.7K |
|
1867
Magnite
MGNI
$3.4B
| $21K | ﹤0.01% |
2,261
-529
| -19% | -$4.91K |
|
1868
Repare Therapeutics
RPTX
$75.6M
| $21K | ﹤0.01% |
3,008
-6,870
| -70% | -$48K |
|
1869
Aecom
ACM
$16.6B
| $20K | ﹤0.01% |
226
| – | – |
|
1870
Fortive
FTV
$16.2B
| $20K | ﹤0.01% |
277
-2,426
| -90% | -$175K |
|
1871
Manulife Financial
MFC
$52.4B
| $20K | ﹤0.01% |
921
| – | – |
|
1872
uniQure
QURE
$959M
| $20K | ﹤0.01% |
3,040
+110
| +4% | +$724 |
|
1873
CGI
GIB
$20.7B
| $19K | ﹤0.01% |
186
+98
| +111% | +$10K |
|
1874
Principal Financial Group
PFG
$17.8B
| $19K | ﹤0.01% |
246
+6
| +3% | +$463 |
|
1875
Sangamo Therapeutics
SGMO
$160M
| $19K | ﹤0.01% |
37,090
+2,039
| +6% | +$1.05K |
|